| Responsive self-assembled nanostructured lipid systems for drug delivery and diagnostics WK Fong, R Negrini, JJ Vallooran, R Mezzenga, BJ Boyd Journal of colloid and interface science 484, 320-339, 2016 | 127 | 2016 |
| Oil and drug control the release rate from lyotropic liquid crystals I Martiel, N Baumann, JJ Vallooran, J Bergfreund, L Sagalowicz, ... Journal of controlled release 204, 78-84, 2015 | 89 | 2015 |
| Macroscopic alignment of lyotropic liquid crystals using magnetic nanoparticles JJ Vallooran, S Bolisetty, R Mezzenga Advanced Materials 34 (23), 3932-3937, 2011 | 72 | 2011 |
| Lipidic cubic phases as a versatile platform for the rapid detection of biomarkers, viruses, bacteria, and parasites JJ Vallooran, S Handschin, SM Pillai, BN Vetter, S Rusch, HP Beck, ... Advanced functional materials 26 (2), 181-190, 2016 | 71 | 2016 |
| Amyloid-mediated synthesis of giant, fluorescent, gold single crystals and their hybrid sandwiched composites driven by liquid crystalline interactions S Bolisetty, JJ Vallooran, J Adamcik, S Handschin, F Gramm, R Mezzenga Journal of colloid and interface science 361 (1), 90-96, 2011 | 70 | 2011 |
| Magnetic-Responsive Hybrids of Fe3O4 Nanoparticles with β-Lactoglobulin Amyloid Fibrils and Nanoclusters S Bolisetty, JJ Vallooran, J Adamcik, R Mezzenga Acs Nano 7 (7), 6146-6155, 2013 | 68 | 2013 |
| Controlling enzymatic activity and kinetics in swollen mesophases by physical nano-confinement W Sun, JJ Vallooran, A Zabara, R Mezzenga Nanoscale 6 (12), 6853-6859, 2014 | 58 | 2014 |
| Controlling Anisotropic Drug Diffusion in Lipid-Fe3O4 Nanoparticle Hybrid Mesophases by Magnetic Alignment JJ Vallooran, R Negrini, R Mezzenga Langmuir 29 (4), 999-1004, 2013 | 54 | 2013 |
| Soft biomimetic nanoconfinement promotes amorphous water over ice L Salvati Manni, S Assenza, M Duss, JJ Vallooran, F Juranyi, S Jurt, ... Nature Nanotechnology 14 (6), 609-615, 2019 | 52 | 2019 |
| Phase behavior of lipid–based lyotropic liquid crystals in presence of colloidal nanoparticles E Venugopal, SK Bhat, JJ Vallooran, R Mezzenga Langmuir 27 (16), 9792-9800, 2011 | 44 | 2011 |
| Twofold light and magnetic responsive behavior in nanoparticle–lyotropic liquid crystal systems JJ Vallooran, S Handschin, S Bolisetty, R Mezzenga Langmuir 28 (13), 5589-5595, 2012 | 40 | 2012 |
| Lyotropic liquid crystalline cubic phases as versatile host matrices for membrane-bound enzymes W Sun, JJ Vallooran, WK Fong, R Mezzenga The journal of physical chemistry letters 7 (8), 1507-1512, 2016 | 37 | 2016 |
| Enzyme kinetics in liquid crystalline mesophases: size matters, but also topology W Sun, JJ Vallooran, R Mezzenga Langmuir 31 (15), 4558-4565, 2015 | 36 | 2015 |
| Volume transition of PNIPAM in a nonionic surfactant hexagonal mesophase VJ Jijo, KP Sharma, R Mathew, S Kamble, PR Rajamohanan, ... Macromolecules 43 (10), 4782-4790, 2010 | 29 | 2010 |
| Efficient asymmetric synthesis of carbohydrates by aldolase nano-confined in lipidic cubic mesophases T Zhou, JJ Vallooran, S Assenza, A Szekrenyi, P Clapes, R Mezzenga ACS Catalysis 8 (7), 5810-5815, 2018 | 26 | 2018 |
| Lipidic Mesophase-Embedded Palladium Nanoparticles: Synthesis and Tunable Catalysts in Suzuki–Miyaura Cross-Coupling Reactions M Duss, JJ Vallooran, L Salvati Manni, N Kieliger, S Handschin, ... Langmuir 35 (1), 120-127, 2018 | 18 | 2018 |
| Templating effects of lyotropic liquid crystals in the encapsulation of amyloid fibrils and their stimuli-responsive magnetic behavior I Amar-Yuli, J Adamcik, C Lara, S Bolisetty, JJ Vallooran, R Mezzenga Soft Matter 7 (7), 3348-3357, 2011 | 17 | 2011 |
| Spatiotemporal control of enzyme‐induced crystallization under lyotropic liquid crystal nanoconfinement JJ Vallooran, S Assenza, R Mezzenga Angewandte Chemie 131 (22), 7367-7371, 2019 | 13 | 2019 |
| Ion-mediated morphological diversity in protein amyloid systems H Chaaban, JJ Vallooran, M van de Weert, V Fodera The journal of physical chemistry letters 13 (16), 3586-3593, 2022 | 9 | 2022 |
| Polypeptides: PASylation and XTEN R Anand, J Vallooran Engineering of biomaterials for drug delivery systems, 299-315, 2018 | 9 | 2018 |
